Cytoplasmic HuR expression correlates with angiogenesis, lymphangiogenesis, and poor outcome in lung cancer

[1]  J. Soria,et al.  The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancer. , 2010, Clinical lung cancer.

[2]  K. Syrigos,et al.  Targeted therapy for nonsmall cell lung cancer: focusing on angiogenesis, the epidermal growth factor receptor and multikinase inhibitors , 2010, Anti-cancer drugs.

[3]  M. Yashiro,et al.  Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model , 2009, British Journal of Cancer.

[4]  M. Detmar,et al.  Lymphangiogenesis and cancer metastasis , 2009, Journal of cellular and molecular medicine.

[5]  S. Choi,et al.  Cytoplasmic expression of HuR is related to cyclooxygenase-2 expression in colon cancer. , 2009, Cancer research and treatment : official journal of Korean Cancer Association.

[6]  Y. Totsuka,et al.  HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cells , 2009, British Journal of Cancer.

[7]  M. Gorospe,et al.  The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase. , 2009, Cancer research.

[8]  Jun Wang,et al.  The Expression of RNA-Binding Protein HuR in Non-Small Cell Lung Cancer Correlates with Vascular Endothelial Growth Factor-C Expression and Lymph Node Metastasis , 2009, Oncology.

[9]  K. Alitalo,et al.  VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. , 2009, Current opinion in cell biology.

[10]  Jung Hur,et al.  Emerging roles of RNA and RNA-binding protein network in cancer cells. , 2009, BMB reports.

[11]  M. Santini,et al.  Expression of the embryonic lethal abnormal vision‐like protein HuR in human mesothelioma , 2008, Cancer.

[12]  D. Wong,et al.  AUF1 and HuR Proteins Stabilize Interleukin-8 mRNA in Human Saliva , 2008, Journal of dental research.

[13]  Jun Wang,et al.  Artemisinin Inhibits Tumor Lymphangiogenesis by Suppression of Vascular Endothelial Growth Factor C , 2008, Pharmacology.

[14]  H. Lou,et al.  Diverse molecular functions of Hu proteins , 2008, Cellular and Molecular Life Sciences.

[15]  R. Haba,et al.  The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients. , 2008, European journal of cancer.

[16]  H. Takeuchi,et al.  Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human meningiomas , 2008, Journal of Neuro-Oncology.

[17]  G. Nilsson,et al.  Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice. , 2007, Cancer research.

[18]  H. Nevanlinna,et al.  Prognostic Role of HuR in Hereditary Breast Cancer , 2007, Clinical Cancer Research.

[19]  K. Phoenix,et al.  Double-Stranded RNA-Binding Protein Regulates Vascular Endothelial Growth Factor mRNA Stability, Translation, and Breast Cancer Angiogenesis , 2007, Molecular and Cellular Biology.

[20]  K. Miyazono,et al.  Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. , 2007, Cancer research.

[21]  T. Zou,et al.  HIV protease inhibitors increase TNF-α and IL-6 expression in macrophages: Involvement of the RNA-binding protein HuR , 2007 .

[22]  C. Song,et al.  COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia , 2007, British Journal of Cancer.

[23]  Robert Gray,et al.  Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. , 2006, The New England journal of medicine.

[24]  D. Goukassian,et al.  IL‐10‐induced TNF‐alpha mRNA destabilization is mediated via IL‐10 suppression of p38 MAP kinase activation and inhibition of HuR expression , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  M. Yasuno,et al.  Coexpression of VEGF-C and Cox-2 in Human Colorectal Cancer and its Association With Lymph Node Metastasis , 2006, Diseases of the colon and rectum.

[26]  J. Berlin,et al.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.

[27]  S. Gately,et al.  Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. , 2004, Seminars in oncology.

[28]  C. Haglund,et al.  Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. , 2003, Cancer research.

[29]  S. Oliviero,et al.  β-Catenin Inversely Regulates Vascular Endothelial Growth Factor-D mRNA Stability* , 2003, Journal of Biological Chemistry.

[30]  T. Hla,et al.  The RNA-binding Protein HuR Regulates the Expression of Cyclooxygenase-2* , 2003, Journal of Biological Chemistry.

[31]  L. Dwyer-Nield,et al.  Differential Expression and Localization of the mRNA Binding Proteins, AU‐Rich Element mRNA Binding Protein (AUF1) and Hu Antigen R (HuR), in Neoplastic Lung Tissue , 2000, Molecular carcinogenesis.

[32]  Myriam Gorospe,et al.  HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation , 2000, The EMBO journal.

[33]  M. Gorospe,et al.  Global analysis of HuR-regulated gene expression in colon cancer systems of reducing complexity. , 2004, Gene expression.